Workflow
1 Wall Street Analyst Thinks Pfizer Stock Is Going to $45. Is It a Buy Around $26?
PFEPfizer(PFE) The Motley Fool·2024-03-07 14:21

Per Cantor Fitzgerald analyst Louise Chen's calculations published March 4, Pfizer's (PFE 4.26%) stock is going to climb by around 75% to reach or surpass 45overthecomingquarters.Chen′shypothesisforthebiopharmaislikelylinkedtoitsongoingpivotawayfromitscoronavirusmedicineslikePaxlovidandComirnaty,andtowardtherevenuesourcesofthefuture,whichmanagementhasdesignatedascancertherapeutics.ButisPfizerabuytoday,withapricetagaround45 over the coming quarters. Chen's hypothesis for the biopharma is likely linked to its ongoing pivot away from its coronavirus medicines like Paxlovid and Comirnaty, and toward the revenue sources of the future, which management has designated as cancer therapeutics.But is Pfizer a buy today, with a price tag around 26, and with its new oncology pipel ...